Crossmark

Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort

Crossref DOI link: https://doi.org/10.1038/s41598-025-10447-7

Published Online: 2025-07-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Madhavan, Ramya

Gupta, Divya

Paul, Jackwin Sam

Babji, Sudhir

Syed, Chanduni

Saravanan, Poornima

Kumar, Ajith

Immanuel, Sushil

Gandhi, Vaishnavi

Eswaran, Akilandeswari

Dhanapal, Pavithra

Raj, Lakshmi

Gopal, Soundari

Thamizh, Isai

Kumar, Dilesh

George, Anna

Kang, Gagandeep

John, Jacob
Funding

Funding for this research was provided by:

Bill and Melinda Gates Foundation (INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915, INV-024915)
License Information

Text and Data Mining valid from 2025-07-09

Version of Record valid from 2025-07-09
More Information

Article History

Received: 10 February 2025

Accepted: 3 July 2025

First Online: 9 July 2025

Declarations

:

: The authors declare no competing interests.

: The study has been approved by the Institutional Review Board of Christian Medical College, Vellore (IRB min no: 13585). We certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

: Written informed consent was obtained from all participants.

Document is current

Any future updates will be listed below